Clinical Trials on Cell & Gene Therapy
Clinical Trials of Cell and Gene Therapy products often varying from the clinical trials design for other types of pharmaceutical products. This differences in trial design are necessitated by the distinctive features of these products. The clinical trials also reflect previous clinical experience and evidence of medicine. Early experiences with Cell and Gene Therapy products indicate that some CGT products may pose substantial risks to subjects due to effect at cellular and genetic level. The design of early-phase clinical trials of Cell and Gene Therapy products often involves the following consideration of clinical safety issues, preclinical issues, and chemistry, manufacturing and controls (CMC) issues that are encountered.
- Gene Therapy Techniques
- Gene Therapy Challenges
Related Conference of Clinical Trials on Cell & Gene Therapy
21th World Congress on Tissue Engineering Regenerative Medicine and Stem Cell Research
16th International Conference on Human Genetics and Genetic Diseases
19th International Conference on Genomics & Pharmacogenomics
Clinical Trials on Cell & Gene Therapy Conference Speakers
Recommended Sessions
- Advanced Gene Therapeutics
- Bioengineering Therapeutics
- Cell and Gene Therapy for Rare & Common Diseases
- Cell Culture and Bioprocessing
- Cell Science and stem cell research
- Cell Therapy
- Cell Therapy for Cardiovascular and Neurological Disorders
- Clinical Trials on Cell & Gene Therapy
- Ethical Issues in Cell and Gene Therapy
- Gene Therapy
- Genetics & Genomic Medicine
- Genome Editing
- Markets & Future Prospects for Cell & Gene Therapy
- Molecular Basis of Epigenetics
- Nano Therapy
- Regulatory and Safety Aspects of Cell and Gene Therapy
- Stem Cell Research
- Stem Cell Therapies
- Tissue Engineering & Regenerative Medicine
- Viral Gene Therapy
Related Journals
Are you interested in
- Artificial Intelligence and Computational Biology in Regenerative Medicine - Stemgen 2026 (France)
- Biomaterials and Nanotechnology in Regenerative Medicine - Stemgen 2026 (France)
- Cancer Stem Cells and Oncology - Stemgen 2026 (France)
- Cardiovascular Regeneration - Stemgen 2026 (France)
- Clinical Trials and Translational Stem Cell Research - Stemgen 2026 (France)
- Ethical, Legal, and Social Implications in Stem Cell Research - Stemgen 2026 (France)
- Future Trends: Organoids, Bioengineering, and Next-Generation Therapies - Stemgen 2026 (France)
- Gene Editing and CRISPR Technologies - Stemgen 2026 (France)
- Induced Pluripotent Stem Cells (iPSCs) and Reprogramming - Stemgen 2026 (France)
- Mesenchymal Stem Cells (MSCs) in Therapy - Stemgen 2026 (France)
- Regenerative Dentistry and Craniofacial Applications - Stemgen 2026 (France)
- Regenerative Medicine and Tissue Engineering - Stemgen 2026 (France)
- Stem Cell Banking and Cryopreservation - Stemgen 2026 (France)
- Stem Cell Biology and Cellular Mechanisms - Stemgen 2026 (France)
- Stem Cells in Neurological and Neurodegenerative Disorders - Stemgen 2026 (France)